Quarterly Consolidated Balance Sheet

Modalis Therapeutics Corporation - Filing #7272022

Concept As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Quarterly consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
2,978,361,000 JPY
3,575,277,000 JPY
1,883,437,000 JPY
1,301,371,000 JPY
Other
18,019,000 JPY
41,661,000 JPY
66,533,000 JPY
19,550,000 JPY
Current assets
3,005,142,000 JPY
3,617,079,000 JPY
1,956,323,000 JPY
1,413,540,000 JPY
Non-current assets
Property, plant and equipment
Accumulated depreciation
-582,023,000 JPY
-524,709,000 JPY
Investments and other assets
463,553,000 JPY
74,469,000 JPY
69,601,000 JPY
406,597,000 JPY
Investments and other assets
Other
1,667,000 JPY
1,667,000 JPY
Allowance for doubtful accounts
JPY
-9,213,000 JPY
Non-current assets
463,553,000 JPY
74,469,000 JPY
69,601,000 JPY
406,597,000 JPY
Assets
3,468,695,000 JPY
3,691,549,000 JPY
2,025,925,000 JPY
1,820,138,000 JPY
Liabilities
Current liabilities
Income taxes payable
16,496,000 JPY
16,496,000 JPY
5,973,000 JPY
5,973,000 JPY
Other
1,179,000 JPY
1,246,000 JPY
Current liabilities
43,970,000 JPY
117,322,000 JPY
198,101,000 JPY
22,490,000 JPY
Non-current liabilities
Other
21,701,000 JPY
30,577,000 JPY
Non-current liabilities
4,446,000 JPY
26,148,000 JPY
447,401,000 JPY
416,823,000 JPY
Liabilities
48,417,000 JPY
143,471,000 JPY
645,502,000 JPY
439,314,000 JPY
Net assets
Shareholders' equity
Share capital
1,758,987,000 JPY
1,758,987,000 JPY
1,217,652,000 JPY
1,217,652,000 JPY
Capital surplus
3,080,722,000 JPY
3,080,722,000 JPY
2,539,387,000 JPY
2,539,387,000 JPY
Retained earnings
-1,441,083,000 JPY
-1,325,620,000 JPY
-2,410,273,000 JPY
-2,402,547,000 JPY
Treasury shares
-97,000 JPY
-97,000 JPY
-97,000 JPY
-97,000 JPY
Shareholders' equity
3,398,529,000 JPY
3,513,992,000 JPY
1,346,669,000 JPY
1,354,394,000 JPY
Valuation and translation adjustments
Foreign currency translation adjustment
12,337,000 JPY
7,323,000 JPY
Valuation and translation adjustments
12,337,000 JPY
7,323,000 JPY
Share acquisition rights
21,748,000 JPY
21,748,000 JPY
26,430,000 JPY
26,430,000 JPY
Net assets
21,748,000 JPY
-1,325,620,000 JPY
-1,441,083,000 JPY
2,513,987,000 JPY
21,748,000 JPY
3,420,278,000 JPY
1,758,987,000 JPY
3,513,992,000 JPY
12,337,000 JPY
1,758,987,000 JPY
3,080,722,000 JPY
-97,000 JPY
-97,000 JPY
12,337,000 JPY
3,548,078,000 JPY
3,080,722,000 JPY
566,735,000 JPY
-1,441,083,000 JPY
3,398,529,000 JPY
-97,000 JPY
7,323,000 JPY
1,380,422,000 JPY
26,430,000 JPY
566,735,000 JPY
1,217,652,000 JPY
26,430,000 JPY
1,346,669,000 JPY
7,323,000 JPY
1,217,652,000 JPY
2,539,387,000 JPY
1,380,824,000 JPY
-2,410,273,000 JPY
-2,402,547,000 JPY
1,354,394,000 JPY
1,972,652,000 JPY
2,539,387,000 JPY
-97,000 JPY
-2,402,547,000 JPY
2,941,232,000 JPY
-2,586,894,000 JPY
2,905,825,000 JPY
18,923,000 JPY
-97,000 JPY
2,943,201,000 JPY
16,483,000 JPY
3,416,502,000 JPY
2,849,767,000 JPY
3,416,502,000 JPY
2,924,277,000 JPY
-2,605,346,000 JPY
-97,000 JPY
2,094,767,000 JPY
2,094,767,000 JPY
16,483,000 JPY
-2,586,894,000 JPY
566,735,000 JPY
18,923,000 JPY
Liabilities and net assets
3,468,695,000 JPY
3,691,549,000 JPY
2,025,925,000 JPY
1,820,138,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.